2026 Q1 Portfolio Activity
In 2026 Q1, SUPERSTRING CAPITAL MANAGEMENT LP maintained a portfolio of 60 distinct positions. The most significant new addition was SUMMIT THERAPEUTICS INC, now representing 12.09% of the total fund value. They heavily accumulated shares in GENMAB A/S, increasing the position by 574.5%. Conversely, SUPERSTRING CAPITAL MANAGEMENT LP completely exited their position in CIDARA THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
60
Quarter
2026 Q1
Top Holding
SMMT (12.1%)
Top 10 Concentration
57.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 60
SUPERSTRING CAPITAL MANAGEMENT LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 12.09% | — |
#1
Prev: #—
|
9.5 |
—
|
892,873 | — |
NEW
|
892,873 | $16,928,872 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 6.35% | 3.93% |
#2
5
Prev: #7
|
6.5 |
—
|
68,929 | 23.9% |
P
S
|
357,606 | $8,882,933 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.19% | 6.96% |
#3
1
Prev: #4
|
3.5 |
—
|
-141,080 | -38.5% |
P
S
|
225,158 | $8,666,331 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 6.19% | 3.21% |
#4
5
Prev: #9
|
6.0 |
—
|
590,624 | 59.3% |
P
S
|
1,585,977 | $8,659,434 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 4.98% | 9.01% |
#5
2
Prev: #3
|
2.5 |
—
|
-330,983 | -46.1% |
P
S
|
387,371 | $6,964,931 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 4.75% | — |
#6
Prev: #—
|
5.4 |
—
|
351,461 | — |
NEW
|
351,461 | $6,642,613 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 4.68% | — |
#7
Prev: #—
|
5.4 |
—
|
730,548 | — |
NEW
|
730,548 | $6,545,710 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 4.59% | — |
#8
Prev: #—
|
5.3 |
—
|
110,454 | — |
NEW
|
110,454 | $6,418,482 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 4.08% | 1.28% |
#9
16
Prev: #25
|
4.6 |
—
|
91,740 | 103.9% |
P
S
|
180,048 | $5,711,123 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 4.04% | 3.98% |
#10
4
Prev: #6
|
1.6 |
—
|
-39,569 | -21.9% |
P
S
|
141,024 | $5,653,652 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 3.77% | 0.48% |
#11
26
Prev: #37
|
4.5 |
—
|
167,547 | 574.5% |
P
S
|
196,709 | $5,277,702 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 3.71% | 1.86% |
#12
7
Prev: #19
|
4.0 |
—
|
78,965 | 40.1% |
P
S
|
275,818 | $5,188,137 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 3.51% | — |
#13
Prev: #—
|
4.9 |
—
|
11,010 | — |
NEW
|
11,010 | $4,916,405 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IQV
IQVIA HLDGS INC
|
Healthcare | 3.13% | — |
#14
Prev: #—
|
4.8 |
—
|
25,668 | — |
NEW
|
25,668 | $4,377,421 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 2.79% | — |
#15
Prev: #—
|
4.6 |
—
|
192,139 | — |
NEW
|
192,139 | $3,906,186 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ARVN
ARVINAS INC
|
Healthcare | 2.37% | — |
#16
Prev: #—
|
4.4 |
—
|
312,620 | — |
NEW
|
312,620 | $3,313,772 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 2.23% | — |
#17
Prev: #—
|
4.4 |
—
|
63,591 | — |
NEW
|
63,591 | $3,119,139 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.20% | 2.47% |
#18
3
Prev: #15
|
0.9 |
—
|
-4,265 | -45.1% |
P
S
|
5,186 | $3,075,194 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.18% | 0.78% |
#19
12
Prev: #31
|
3.9 |
—
|
64,732 | 170.2% |
P
S
|
102,754 | $3,052,821 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 2.14% | 0.99% |
#20
9
Prev: #29
|
3.9 |
—
|
103,274 | 69.6% |
P
S
|
251,566 | $3,001,182 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ANL
ADLAI NORTYE LT...
|
Healthcare | 2.05% | — |
#21
Prev: #—
|
4.3 |
—
|
414,852 | — |
NEW
|
414,852 | $2,870,776 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 2.05% | 2.64% |
#22
8
Prev: #14
|
0.8 |
—
|
-1,187,311 | -52.7% |
P
S
|
1,066,239 | $2,868,183 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PFE
PFIZER INC
|
Healthcare | 1.48% | — |
#23
Prev: #—
|
4.1 |
—
|
74,000 | — |
NEW
|
74,000 | $2,077,920 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.35% | 3.66% |
#24
16
Prev: #8
|
0.5 |
—
|
-26,216 | -70.0% |
P
S
|
11,217 | $1,895,897 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.04% | 1.12% |
#25
2
Prev: #27
|
0.4 |
—
|
-140,136 | -54.9% |
P
S
|
115,234 | $1,460,015 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 0.98% | — |
#26
Prev: #—
|
3.9 |
—
|
366,490 | — |
NEW
|
366,490 | $1,374,338 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.97% | — |
#27
Prev: #—
|
3.9 |
—
|
199,209 | — |
NEW
|
199,209 | $1,364,582 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.82% | 2.89% |
#28
17
Prev: #11
|
0.3 |
—
|
-722,499 | -73.7% |
P
S
|
258,269 | $1,154,462 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.69% | 1.98% |
#29
11
Prev: #18
|
0.3 |
—
|
-33,967 | -71.8% |
P
S
|
13,311 | $971,304 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TNXP
TONIX PHARMACEU...
|
Healthcare | 0.62% | — |
#30
Prev: #—
|
3.7 |
—
|
63,540 | — |
NEW
|
63,540 | $873,675 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 0.60% | — |
#31
Prev: #—
|
3.7 |
—
|
59,484 | — |
NEW
|
59,484 | $845,268 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 0.45% | 1.03% |
#32
4
Prev: #28
|
0.2 |
—
|
-238,543 | -66.3% |
P
S
|
121,457 | $632,791 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PTN
PALATIN TECHNOL...
|
Healthcare | 0.45% | 0.28% |
#33
8
Prev: #41
|
2.2 |
—
|
1,998 | 5.9% |
P
S
|
35,969 | $626,580 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BMEA
BIOMEA FUSION I...
|
Healthcare | 0.27% | 0.17% |
#34
10
Prev: #44
|
1.1 |
—
|
no change | no change |
P
S
|
250,000 | $382,500 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.19% | 0.25% |
#35
8
Prev: #43
|
0.1 |
—
|
-343,655 | -74.2% |
P
S
|
119,308 | $269,636 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ENTX
ENTERA BIO LTD
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #45) |
0.0 |
—
|
-17,142 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #42) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.39% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-31,738 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 0.44% |
Sold All 😨
(Was: #39) |
0.0 |
—
|
-72,060 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-367,103 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-69,496 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.00% | 0.57% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-12,137 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.00% | 0.58% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-26,249 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.00% | 0.65% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-513,765 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.00% | 0.72% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-43,230 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 0.00% | 0.83% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-58,677 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 0.00% | 1.19% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-65,273 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.00% | 1.43% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-25,469 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-96,334 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-153,313 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-50 of 60 holdings